Skip to main content
logo
BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
301.01
+0.21 (0.07%)
Apr 27, 2026, 11:59 AM EDT - Market open

BeOne Medicines AG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
10,8077,5692,4591,4161,176
Revenue Growth (YoY)
42.77%207.85%73.65%20.37%280.83%
Cost of Revenue
668.54594.09379.92286.48164.91
Gross Profit
10,1386,9752,0791,1291,011
Selling, General & Admin
2,0811,8311,5081,279990.12
Depreciation & Amortization Expenses
----0.75
Research & Development
4,3623,8911,7791,6411,459
Total Operating Expenses
6,4445,7223,2872,9192,450
Operating Income
447.14-568.2-1,208-1,790-1,439
Interest Income
70.5169.64---
Interest Expense
-77.81-44.88-4.36--
Other Non-Operating Income (Expense)
27.9557386.26-171.370.15
Total Non-Operating Income (Expense)
20.6581.76381.9-171.370.15
Pretax Income
788-1,103-825.84-1,961-1,439
Provision for Income Taxes
292.29223.5355.8742.7819.23
Net Income
208.78-682.04-881.71-2,004-1,458
Net Income to Common
208.78-682.04-881.71-2,004-1,458
Shares Outstanding (Basic)
10910510410393
Shares Outstanding (Diluted)
11310510410393
Shares Change (YoY)
7.75%0.86%1.22%11.15%11.16%
EPS (Basic)
2.60-6.11-8.45-19.37-15.73
EPS (Diluted)
2.47-6.11-8.45-19.37-15.73
Shares Outstanding
110.85106.72104.58104.32102.68
Free Cash Flow
941.74-633.29-1,719-1,822-1,562
Free Cash Flow Per Share
8.30-6.01-16.47-17.67-16.83
Gross Margin
93.81%92.15%84.55%79.77%85.98%
Operating Margin
4.14%-7.51%-49.12%-126.40%-122.31%
Profit Margin
2.66%-8.52%-35.86%-141.52%-123.93%
FCF Margin
8.71%-8.37%-69.93%-128.68%-132.76%
EBITDA
588.82-396.44-1,120-1,723-1,392
EBITDA Margin
5.45%-5.24%-45.55%-121.71%-118.36%
EBIT
447.14-568.2-1,208-1,790-1,439
EBIT Margin
4.14%-7.51%-49.12%-126.40%-122.31%
Effective Tax Rate
37.09%-20.26%-6.77%-2.18%-1.34%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q